Join
Live feed
·
INSIDERFilingvia Quantisnow
Reata Pharmaceuticals Inc. logo

SEC Form 4: Bir Dawn Carter sold $203,409 worth of shares (1,205 units at $168.80), decreasing direct ownership by 3% to 33,805 units

ByQuantisnow·Wall Street's wire, on your screen.
RETA· Reata Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RETA (Reata Pharmaceuticals Inc.) and more on Quantisnow.